Orthopaedic surgeons appear reluctant to initiate early bisphosphonate therapy following fragility fractures due to misperceptions about bone healing, a Victorian study suggests. According to a retrospective audit of practice at Boxhill Hospital, only 32 (18%) of 181 patients with fragility fractures likely to be due to osteoporosis were started on bisphosphonates. A survey of orthopaedic ...
Orthopaedic surgeon attitudes a barrier to bisphosphonate use after fragility fractures
By Mardi Chapman
5 Apr 2018